NEWS
NEW SERVICE TO TREAT PATIENTS AT LANARKSHIRE PHARMACIES
In the September issue of SP, we looked at a great initiative that had been launched in Inverclyde. ‘Pharmacy First’ allows patients to access advice and/or treatment for uncomplicated urinary tract iInfection in women aged between 16 and 65 and impetigo for any adult or child over two years of age without having to see their GP fi rst.
Now the initiative has been rolled out throughout Scotland and has been welcomed across the board.
‘Both of these conditions are very common among the general population and often account for a signifi cant proportion of GP and out of hours appointments,’ said George Lindsay, Chief Pharmacist, Primary Care, NHS Lanarkshire. ‘Pharmacists
are qualifi ed healthcare professionals who train for many years in their fi eld. It makes absolute sense to use their skills and knowledge to increase access to clinical advice - and treatment where appropriate - for patients within their community.
‘We have 144 community pharmacies across Lanarkshire and, given the current, national pressures facing general medical and out-of-hours services, the benefi ts of pharmacists supporting the GP role in this way is invaluable.’
Arif Hanif, the Chairman of Community Pharmacy Lanarkshire, described how pharmacy teams are throwing their support behind this exciting new service.
‘Community pharmacies provide
unrivalled access to both healthcare professionals and highly trained support staff, without the need for an appointment in most cases,’ he said. ‘We are delighted to now be able to treat these two very common conditions as part of our suite of NHS services, supporting the people of
5793 Zeroderma quarter page advertorials v1.qxp_Zeroderma quarter page ad
Lanarkshire to access the right care from the right person at the right time, as close to home as possible. We are committed to making this service a success, and look forward to developing more ways in which to ease the pressure on our GPs and NHS24.’
Over £880,000 savings1 for NHS Scotland with Zeroderma
Wellbeing support through workshops and online resources
Financial assistance and advice in times of hardship
500g NEW
NEW pump
WE CAN HELP
Free, confidential, independent support and advice
A listening ear in times of stress
By changing from branded emollients to the cost effective Zeroderma emollient range, NHS Scotland could save over £880,000 a year and one Scottish Health Board could save over £142,000 p.a. without compromising on patient care.
The Zeroderma range offers products similar in formulation to around 60% of currently prescribed emollients and offers cost savings of up to 37%.
Information and online resources
Specialist addiction counselling
Pharmacist Support – the profession’s independent charity Call: 0808 168 2233 Visit:
www.pharmacistsupport.org Email:
info@pharmacistsupport.org
Pharmacist Support is a charitable company limited by guarantee registered in England & Wales, company no 9237609 & charity no 1158974
Many Health Boards and CCGs have adopted the Zeroderma range onto their formularies and cost savings are being made without compromising on patient care.
To find out how much your Health Board could save visit our QIPP and Emollients toolkit at
qipp.zeroderma.co.uk, developed by Medicines Management teams it contains everything needed to implement product changes at practice level, as well as a guide to the savings your Health Board could make.
For further information or samples for patient evaluation, email:
zeroderma@thorntonross.com or visit
www.zeroderma.co.uk
Thornton & Ross, Linthwaite, Huddersfield. HD7 5QH
Phone: 01484 842217 | Web:
www.zeroderma.co.uk 1. PCA data, October 2017
SCOTTISH PHARMACIST - 43
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48